1 terminated, 1 unknown. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow D-Aspartic Acid: new trials by email Literature Review of D-Aspartic Acid trials Research Report on D-Aspartic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS) D-aspartate, Placebo, IFN beta-1a - Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 7 | 2018-03-26 | 2020-02-10 |
| D-aspartate and Therapeutic Exercise D-Aspartate, Therapeutic exercise, Placebo Oral Tablet - Brain Injuries | Early Phase 1 | Unknown | Neuromed IRCCS | 100 | 2017-11-22 | 2019-03-15 |
Brain Injuries (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Merck KGaA, Darmstadt, Germany (1) · Neuromed IRCCS (1)
Italy (2)